Pacific Biosciences of California, Inc.
) was a big mover last session with its shares rising over 8% on
the day. The move came on solid volume too with far more shares
changing hands than in a normal session. This reverses the recent
trend of the company, as the stock has lost over 9% in the past
one-month time frame.
This biotechnology company has seen no estimate revision in the
last 7 days. The Zacks Consensus Estimate hasn't been in trend
either. Yesterday's price action is encouraging though, so make
sure to keep a close watch on this firm in the near future.
Pacific Biosciences currently has a Zacks Rank #3 (Hold) while its
Some better-ranked Med-Drug stocks include
Natus Medical Inc.
). While BABY sports a Zacks Rank #1 (Strong Buy), ANGO and CYBX
carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
ANGIODYNAMICS (ANGO): Free Stock Analysis
NATUS MEDICAL (BABY): Free Stock Analysis
CYBERONICS INC (CYBX): Free Stock Analysis
PACIFIC BIOSCI (PACB): Free Stock Analysis
To read this article on Zacks.com click here.